(Q24302326)

GOA release 2020-03-11

hydrolase activity

1 reference

GOA release 2020-03-11

author

Eleftherios P. Diamandis

6

object named as

Eleftherios P Diamandis

0 references

Ali Awsat Mellati

object named as

Ali Awsat Mellati

3

0 references

Gregory A Wasney

5

object named as

Gregory A Wasney

0 references

author name string

Carl Kapadia

1

0 references

George M Yousef

2

0 references

Angeliki Magklara

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

4

0 references

language of work or name

English

0 references

publication date

January 2004

0 references

published in

Clinica Chimica Acta

0 references

volume

339

0 references

page(s)

157-67

0 references

issue

1-2

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Prostate-specific antigen in management of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Characterization of the human kallikrein locus

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Expression of the protease inhibitor antileukoprotease and the serine protease stratum corneum chymotryptic enzyme (SCCE) is coordinated in ovarian tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Human Kallikrein 13: Production and Purification of Recombinant Protein and Monoclonal and Polyclonal Antibodies, and Development of a Sensitive and Specific Immunofluorometric Assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021

Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCCN.2003.10.009

7 January 2021